FDA NDC Directory · JSON-LD · Markdown

LIKMEZ

NDC 81033-066 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameMetronidazole Oral
Labeler / ManufacturerKesin Pharma Corporation
Marketing categoryNew Drug Application (innovator) · App NDA216755
Dosage form / routeSUSPENSION · ORAL
Active ingredientsMETRONIDAZOLE (100 mg/mL)
Marketing started20231013
Package count1

External sources

Source: openFDA. Public-domain (CC0).